| Completed | Study to Investigate the Effect of BL-8040 (Motixafortide) on the QTc Interval in Healthy Subjects Healthy Subjects | Phase 1 | 2021-06-11 |
| Active Not Recruiting | A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and Granulocyte Colony Stim Multiple Myeloma | Phase 3 | 2018-03-23 |
| Terminated | Safety, Tolerability and Efficacy of the BL-8040 and Atezolizumab for Maintenance Treatment in Subjects With A Acute Myeloid Leukemia | Phase 1 / Phase 2 | 2018-01-08 |
| Completed | Study Assessing Safety and Efficacy of Combination of BL-8040 and Pembrolizumab in Metastatic Pancreatic Cance Metastatic Pancreatic Adenocarcinoma | Phase 2 | 2016-09-01 |
| Completed | Phase IIA Open Label Study to Evaluate Efficacy and Safety of BL-8040 Followed by (hATG), Cyclosporine and Met Aplastic Anemia, Hypoplastic Myelodysplastic Syndrome | Phase 2 | 2015-10-01 |
| Completed | A Phase I Study Evaluating Safety, Tolerability, PK and PD of BL-8040 for Stem Cell Mobilization in Healthy Vo Mobilization of Hematopoietic Stem Cells (HSC) to Peripheral Blood (PB) | Phase 1 | 2014-08-01 |
| Completed | Safety and Systemic Exposure Study of BL-7010 in Well-Controlled Celiac Patients. Celiac Disease | Phase 1 / Phase 2 | 2013-12-01 |
| Terminated | Efficacy, Safety and Tolerability of Ribavirin Monotherapy Followed by Combined Treatment With Ribavirin and H Hepatitis C | Phase 1 / Phase 2 | 2013-04-01 |
| Completed | Phase IIa Study Evaluating Safety and Efficacy of BL-8040 in Relapsed/Refractory AML Patients Acute Myeloid Leukemia | Phase 2 | 2013-04-01 |
| Completed | Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerat Ulcerative Colitis | Phase 2 | 2012-03-01 |
| Terminated | A Study Intended to Evaluate Safety, Tolerability and Pharmacokinetics (PK) Parameters of BL-1021 Healthy, Volunteers | Phase 1 | 2011-06-01 |
| Terminated | Phase IIb-III Study of BL-1020 Small Molecule for Schizophrenia Schizophrenia, Cognitive Effect on Schizophrenic Patients | Phase 2 / Phase 3 | 2011-05-01 |
| Completed | A Six-week, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center, Phase II Study Schizophrenia | Phase 2 | 2008-07-01 |
| Completed | Extension Study To Evaluate The Long-Term Safety, Tolerability, And Efficacy Of Low And High Doses Of Bl-1020 Schizophrenia | Phase 2 | 2008-06-01 |
| Unknown | Safety and Feasibility of the Injectable BL-1040 Implant Cardiovascular Disease | Phase 1 / Phase 2 | 2008-03-01 |
| Completed | Safety and Tolerability of BL-1020 in Hospitalized Subjects With Chronic Schizophrenia or Schizo-Affective Dis Schizophrenia, Schizoaffective Disorder | Phase 2 | 2007-06-01 |
| Completed | A Positron Emission Tomography (PET) Study to Assess the Degree of Dopamine-2 (D2) Receptor Occupancy in the H Healthy | Phase 1 | 2007-05-01 |
| Completed | A Study of the Safety and Efficacy of Combination Therapy With Morphine, Phenylephrine and Sorbitol in Human S Acute Pain | Phase 1 / Phase 2 | 2006-09-01 |